LANGHORNE, Pa. — Insight Pharmaceuticals is strengthening its portfolio of over-the-counter products with its acquisition of a popular at-home pregnancy test.
Insight said that e.p.t. will join other Insight brands, including Sucrets, Nix, Bonine and Gentle Naturals. As the first FDA-approved, commercially available home pregnancy test, e.p.t. aligns with Insight's strategy to build "a significant portfolio of OTC and personal care products," Insight's CEO Gary Downing said.